Utilizing SAMHSA Grants for Substance Use Treatment

SAMHSA Grants for MAT Services

The Substance Abuse and Mental Health Services Administration (SAMHSA) supports addiction treatment through various grant programs designed to enhance medication-assisted treatment (MAT) services.

Prescription Drug/Opioid Addiction Grants

The SAMHSA Medication-Assisted Treatment - Prescription Drug and Opioid Addiction grants are specifically targeted towards expanding access for individuals with an opioid use disorder (OUD). The primary goal of these grants is to increase the number of individuals receiving MAT and to decrease illicit opioid drug use and prescription opioid misuse over a six-month follow-up period. The focus on MAT services ensures that individuals have the necessary support and medication to aid in their recovery journey, providing a strong foundation for managing addiction.

Eligible applicants for these grants include states, tribal organizations, health facilities, and nonprofit private entities. This inclusivity fosters a broad range of programs that can tackle the opioid crisis effectively.

Funding Allocation for FY 2021

For fiscal year 2021, SAMHSA has allocated a total of $71,322,952 for the MAT grants. This significant funding aims to support numerous projects aimed at mitigating the impact of opioid addiction. The anticipated distribution of funds is as follows:

Funding Overview	Amount
Total Available Funding	$71,322,952
Funding for Federally Recognized Tribes/Tribal Organizations	At least $11,000,000
Anticipated Number of Awards	89 to 135
Maximum Award Amount for States	Up to $1,000,000 per year
Maximum Award Amount for Other Entities	Up to $525,000 per year
Project Duration	Up to 5 years
Cost Sharing/Match Requirement	None

The funding allocation structure ensures that various entities, especially those serving underrepresented populations like tribal organizations, receive support. This comprehensive approach serves to enhance the effectiveness of substance use treatment initiatives, ultimately benefitting individuals battling opioid use disorders.

For more detailed information on funding options, visit our page on funding for substance use treatment programs.

Program Details and Eligibility

SAMHSA grants are designed to enhance the availability and effectiveness of treatment services for substance use disorders, particularly focusing on medication-assisted treatment (MAT). This section explores the objectives of MAT grants and the specifics regarding funding distribution and awards.

Objectives of MAT Grants

The primary goal of the Medication-Assisted Treatment - Prescription Drug and Opioid Addiction grants is to expand access to MAT services for individuals with opioid use disorder (OUD). SAMHSA aims to increase the number of people receiving MAT and to reduce both illicit opioid use and prescription opioid misuse over a six-month follow-up period. Grants focus on providing comprehensive support for MAT initiatives that can significantly impact the treatment landscape SAMHSA.

Funding Distribution and Awards

For the fiscal year 2021, the total funding available for SAMHSA grants related to medication-assisted treatment is $71,322,952. The funding structure includes specific allocations, including at least $11 million reserved for federally recognized tribes and tribal organizations. The anticipated distribution of awards is as follows:

Grant Type	Total Funding	Number of Awards	Maximum Award Amount (per year)	Project Duration
States	Up to $1 million	89 to 135	Up to $1 million	Up to 5 years
Other Domestic Entities	Up to $525,000	Varies	Up to $525,000	Up to 5 years

This grants program has no cost-sharing or match requirement, which facilitates broader participation from various entities.

In another relevant grant, SAMHSA announced the Medication-Assisted Treatment grant titled TI-23-001, which provides up to $18,200,000 in total funding for OUD initiatives, with an expected 24 awards each offering up to $750,000 per year for a project length of up to five years SAMHSA.

These funding opportunities play a crucial role in expanding treatment options and improving the overall effectiveness of substance use treatment services, aligning with the objectives of SAMHSA's mission to reduce the prevalence of substance use disorders. For further details on related funding programs, refer to funding for substance use treatment programs.

Maintenance of Effort Requirement

The Maintenance of Effort (MOE) requirement is a critical component for states and jurisdictions receiving funding through SAMHSA grants for substance use treatment. It ensures that these entities maintain a baseline level of financial commitment towards substance use prevention and treatment services.

State Funding Obligations

States and jurisdictions are required to keep their aggregate expenditures for authorized activities at a level greater than or equal to the average of those expenditures for the previous two years. This requirement aims to support consistent funding for substance abuse initiatives. If they fail to comply with the MOE requirement, potential consequences may include penalties equivalent to the deficiency for that fiscal year. Additionally, funds from the Federal Substance Abuse Prevention and Treatment (SAPT) Block Grant may be withheld and reallocated to other states based on a specific formula. For more information on funding, visit our article on funding for substance use treatment programs.

Compliance Status	Potential Consequences
MOE Compliant	No penalties; full access to funds
MOE Non-Compliant	Penalties equal to MOE deficiency; possible withholding of federal funds

Waiver Process and Compliance

In certain circumstances, states or jurisdictions can request a waiver of the MOE requirement. If they can demonstrate that the deficiency was due to extraordinary economic conditions during the relevant fiscal years, a waiver may be granted. The SAMHSA Administrator has the authority to determine compliance when the deficiency reported for authorized activities is less than 3% of the required amount.

If a state does not comply with the MOE requirement, they are entitled to a hearing prior to any final decision made regarding non-compliance. Additionally, states can propose a negotiated agreement as an alternative to a non-compliance determination. For more insights on treatment protocols and how they adapt to varying circumstances, explore our article on medication-assisted treatment (MAT) during the coronavirus pandemic.

For more information on the significance of these provisions, visit SAMHSA's resource page. Keeping abreast of these requirements is essential for effective planning and compliance in utilizing SAMHSA grants for substance use treatment.

Reporting and Monitoring

Establishing a robust reporting and monitoring framework is essential for grant recipients to ensure compliance with SAMHSA grants for substance use treatment. This includes adhering to GPRA compliance and conducting thorough program data collection and reporting.

GPRA Compliance for Grant Recipients

Grant recipients are required to follow the Government Performance and Results Act (GPRA) to measure the effectiveness of their programs. Each recipient must periodically review performance data to assess progress, improve project management, and document this information in the Programmatic Progress Report (PPR) as part of their grant obligations.

The GPRA compliance process entails collecting quantitative data on key indicators relevant to the program’s objectives. Recipients are expected to report results in a structured format, enabling consistent oversight and evaluation by SAMHSA.

GPRA Compliance Requirements	Description
Performance Data Review	Regular assessments to track progress towards project goals.
Programmatic Progress Report (PPR)	Formal documentation required to summarize progress, including challenges and accomplishments.
Quantitative Indicator Reporting	Collection of data on critical metrics, such as client demographics, treatment outcomes, and service access.

For specific requirements and templates for PPRs and other necessary documents, grantees can refer to the SAMHSA Grants Reporting Requirements.

Program Data Collection and Reporting

Grantees are also tasked with the collection of comprehensive program data, often involving National Outcome Measures (NOMs). This includes relevant metrics like behavioral health diagnoses, client demographics, functioning, employment, education, and housing status. Data collection occurs at key points: baseline, reassessment, and discharge SAMHSA Grants NOMs Data Collection.

In addition to quantitative data, a narrative description detailing the achieved outcomes is also necessary. Grantees should provide a quarterly report that highlights their findings and showcases any improvements or modifications needed for future efforts. Such thorough data collection is critical for understanding the impact of services provided and facilitating the continuous improvement of substance use treatment programs.

Data Collection Components	Purpose
Behavioral Health Diagnosis	To monitor client health status and treatment effectiveness.
Client Demographics	To ensure diverse population needs are being addressed.
Client Functioning	To assess the overall impact of treatment on client life circumstances.
Employment and Education Outcomes	To evaluate the economic and social advantages gained from treatment.
Housing Stability	To indicate the success of clients in maintaining safe and stable housing environments post-treatment.

Through effective monitoring and comprehensive data reporting, SAMHSA can ensure that the funds allocated through grants are used efficiently to improve substance use treatment programs nationwide. For additional information on funding for substance use treatment programs, please visit our page on funding for substance use treatment programs.

SAMHSA Substance Use Disorder Grants

Focus on Adult and Family Treatment

The SAMHSA Grants to Expand Substance Use Disorder Treatment Capacity in Adult and Family Treatment Drug Courts program is designed to enhance treatment for individuals dealing with substance use disorders (SUD). The program aims to improve various outcomes such as abstinence from substance use, housing stability, employment status, social connectedness, health and behavioral consequences, and reduce criminal justice involvement. This initiative provides essential prevention, harm reduction, treatment, and recovery services for individuals engaging with the court system [1].

Fund Allocation and Project Length

For this grant, a total of $24,400,000 is available to expand treatment capacity, with an anticipated issuance of 61 awards. Each award can amount to up to $400,000 per year. The project duration for these grants can extend up to five years, with no cost-sharing or matching requirement for the awarded funds [1].

Funding Details	Amount
Total Available Funding	$24,400,000
Anticipated Number of Awards	61
Maximum Award Amount	Up to $400,000 per year
Project Length	Up to 5 years
Cost Sharing Requirement	None

The structure of these grants is aligned with the overarching goal of improving treatment access and outcomes for families and individuals grappling with substance use disorders. The program plays a significant role in addressing the complexities associated with substance use treatment and its intersection with the legal system. For more information on funding for substance use treatment programs, interested parties can further explore grant specifications and eligibility criteria.

Program Application and Contacts

Eligibility Criteria and Applications

The eligibility for SAMHSA grants for substance use treatment varies based on specific grant programs. Generally, potential applicants may include state agencies, local governments, tribal entities, and non-profit organizations focused on substance use disorder treatment. Applicants must demonstrate their capacity to manage funds responsibly and effectively deliver treatment services.

Each grant program has unique application requirements, which details can typically be found in the Notice of Funding Opportunity (NOFO) for individual grants. This document outlines necessary documentation, project proposals, and compliance measures that applicants must fulfill. Resources such as templates for Programmatic Progress Reports (PPRs) and National Outcome Measures (NOMs) are also provided within the NOFO to assist applicants in maintaining proper reporting standards SAMHSA Grants Reporting Requirements.

Eligibility Criteria	Description
Type of Entity	State agencies, local governments, tribal entities, non-profits
Capacity	Demonstrated ability to manage grant funds and deliver treatment
Reporting Standards	Compliance with PPRs and NOMs as outlined in NOFO

SAMHSA Program Contacts

For inquiries and assistance regarding program details or application processes, SAMHSA provides specific contacts for potential applicants. Fred Bamfo from the Center for Substance Abuse Treatment can address any program-related issues. For questions related to grants management and budgeting, the Office of Financial Resources, Division of Grants Management is available.

Contact Person	Role	Contact Information
Fred Bamfo	Center for Substance Abuse Treatment	View Contact
Grants Management Contact	Office of Financial Resources, Division of Grants Management	Visit SAMHSA

By reaching out to these contacts, applicants can gain clarity on any issues regarding the grant application process and ensure they meet all eligibility requirements. This can significantly aid in their pursuit of funding for addiction treatment initiatives. For more information about funding availability and guidelines, check out our article on funding for substance use treatment programs.

References